Published in J Virol on March 01, 1994
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol (1995) 6.33
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein. J Virol (2005) 2.89
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol (1994) 2.88
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J Clin Microbiol (1999) 2.68
Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48
Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J Virol (1994) 2.36
Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Rev (2006) 2.28
Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol (1994) 2.06
Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol (1995) 1.99
Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M. J Virol (2000) 1.96
Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests. J Clin Microbiol (2000) 1.95
Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol (2004) 1.76
Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild. J Virol (1994) 1.70
Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization. J Virol (1997) 1.68
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol (1997) 1.64
Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol (1997) 1.62
Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J Virol (1995) 1.48
Universal amplification, next-generation sequencing, and assembly of HIV-1 genomes. J Clin Microbiol (2012) 1.45
Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic site. Nucleic Acids Res (1998) 1.43
Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J Virol (1996) 1.41
Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line. J Virol (1998) 1.38
The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies. Nucleic Acids Res (1997) 1.31
Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses. J Virol (1996) 1.22
Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol (1999) 1.22
Non-M variants of human immunodeficiency virus type 1. Clin Microbiol Rev (2013) 1.05
Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains. J Virol (1999) 1.05
Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1. J Virol (1998) 1.04
Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. J Virol (2010) 1.01
Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. J Clin Microbiol (2009) 0.97
Genetic diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale. J Virol (1997) 0.95
Current status of HIV/AIDS in Cameroon: how effective are control strategies? Int J Environ Res Public Health (2008) 0.93
Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission. J Virol (1996) 0.91
Vif proteins from diverse primate lentiviral lineages use the same binding site in APOBEC3G. J Virol (2013) 0.88
Extent of antigenic diversity in the V3 region of the surface glycoprotein, gp120, of human immunodeficiency virus type 1 group M and consequences for serotyping. J Virol (1998) 0.87
Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain. J Virol (1996) 0.84
Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay. J Clin Microbiol (1997) 0.82
Multicenter evaluation of new double-antigen sandwich enzyme immunoassay for measurement of anti-human immunodeficiency virus type 1 and type 2 antibodies. J Clin Microbiol (1996) 0.81
Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide. Self Nonself (2011) 0.80
The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon. PLoS Pathog (2015) 0.78
Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data. J Virol (2002) 0.77
Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms. AIDS Res Hum Retroviruses (2016) 0.75
Human Immunodeficiency Virus (HIV). Transfus Med Hemother (2016) 0.75
Quantitative detection of human immunodeficiency virus (HIV) antigen by the Enzymun-Test: comparison with alternative assays and nucleic acid sequence-based amplification of HIV type 1 RNA. J Clin Microbiol (1996) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32
Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A (1981) 32.98
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science (1984) 32.33
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science (1984) 15.82
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (1989) 13.92
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (1984) 11.30
Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci U S A (1990) 8.23
Isolation of a new human retrovirus from West African patients with AIDS. Science (1986) 7.97
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (1987) 7.96
Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol (1992) 7.92
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J Virol (1990) 7.90
Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol (1990) 7.85
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science (1990) 6.77
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci U S A (1989) 6.58
Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J Virol (1988) 5.96
AIDS in Africa: an epidemiologic paradigm. Science (1986) 5.88
Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol (1990) 5.45
Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. J Virol (1987) 5.27
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature (1988) 5.09
Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature (1990) 5.02
HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology (1992) 4.70
Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science (1990) 4.43
Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature (1984) 4.35
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature (1992) 4.11
Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol (1989) 3.90
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58
Structural and functional characterization of human immunodeficiency virus tat protein. J Virol (1989) 3.57
A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J Virol (1990) 3.33
Molecular cloning of AIDS-associated retrovirus. Nature (1985) 3.16
Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol (1992) 3.06
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol (1994) 2.88
Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature (1987) 2.86
Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous. Proc Natl Acad Sci U S A (1990) 2.78
Prediction of beta-turns. Biophys J (1979) 2.71
Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol (1993) 2.63
Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. J Virol (1990) 2.63
Functional analysis of CAR, the target sequence for the Rev protein of HIV-1. Science (1989) 2.62
Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS (1989) 2.55
Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo. J Virol (1992) 2.49
Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet (1986) 2.48
Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc Natl Acad Sci U S A (1990) 2.47
An improved technique for the efficient construction of gene libraries by partial filling-in of cohesive ends. Gene (1986) 2.47
Sequence of a novel simian immunodeficiency virus from a wild-caught African mandrill. Nature (1989) 2.45
Molecular cloning of lymphadenopathy-associated virus. Nature (1985) 2.22
Isolation and characterization of simian immunodeficiency virus from mandrills in Africa and its relationship to other human and simian immunodeficiency viruses. J Virol (1988) 2.17
Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee. AIDS (1992) 1.72
Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science (1993) 1.68
Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein. J Virol (1990) 1.68
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science (1987) 1.66
Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin. J Virol (1990) 1.61
A distinct African lentivirus from Sykes' monkeys. J Virol (1993) 1.58
Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity. J Virol (1991) 1.52
Origin and spread of AIDS. Nature (1990) 1.41
HIV-2, the West African AIDS virus. AIDS (1987) 1.35
Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41. J Virol (1992) 1.35
Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope. J Virol (1990) 1.27
Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology (1992) 1.26
HIV-1 origins. A finger on the missing link. Nature (1990) 1.26
Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function. Virology (1992) 1.14
Antigenic evidence of the presence of the aberrant HIV-1ant70 virus in Cameroon and Gabon. AIDS (1993) 1.09
Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system. Proc Natl Acad Sci U S A (1990) 0.99
Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition. Virology (1993) 0.88
Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines. Int J Cancer (1985) 0.88
Analysis of the envelope region of the highly divergent HIV-2ALT isolate extends the known range of variability within the primate immunodeficiency viruses. AIDS Res Hum Retroviruses (1992) 0.81
Complete structure of the hemagglutinin gene from the human influenza A/Victoria/3/75 (H3N2) strain as determined from cloned DNA. Cell (1980) 14.28
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol (1993) 5.26
Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75. Nature (1980) 5.25
Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS (1993) 3.52
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet (1977) 2.65
Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48
Hemorrhagic fever with renal syndrome. Prog Med Virol (1989) 2.38
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun (1998) 2.12
Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag. Virology (1989) 1.91
Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee. Virology (1996) 1.91
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol (2001) 1.85
Detection of human immunodeficiency virus type 1 (HIV-1) in heel prick blood on filter paper from children born to HIV-1-seropositive mothers. J Clin Microbiol (1994) 1.81
The development of specific rRNA-derived oligonucleotide probes for Haemophilus ducreyi, the causative agent of chancroid. J Gen Microbiol (1991) 1.77
Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J Virol (1998) 1.75
Characterization of Dobrava virus: a Hantavirus from Slovenia, Yugoslavia. J Med Virol (1992) 1.73
Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides. Clin Chem (1991) 1.73
Expression of human fibroblast interferon gene in Escherichia coli. Nature (1980) 1.72
Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee. AIDS (1992) 1.72
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol (2000) 1.70
Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol (1999) 1.61
Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin. J Virol (1990) 1.61
Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis (2000) 1.52
Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol (1999) 1.51
Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr (2000) 1.47
DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun (2000) 1.44
Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J Virol (1996) 1.41
Comparative evaluation of 36 commercial assays for detecting antibodies to HIV. Bull World Health Organ (1991) 1.40
Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1997) 1.39
Molecular cloning, nucleotide sequence, and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to pal lipoproteins. Infect Immun (1994) 1.39
Sensitivity of HIV-antibody assays determined by seroconversion panels. AIDS (1994) 1.37
Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res Hum Retroviruses (2000) 1.33
Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes (1994) 1.32
Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol (2000) 1.31
HIV antigen detection in circulating immune complexes. J Virol Methods (1991) 1.30
Identification and heterologous expression of a new dense granule protein (GRA7) from Toxoplasma gondii. Mol Biochem Parasitol (1998) 1.27
Ebola virus virulence for newborn mice. J Med Virol (1979) 1.26
Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. AIDS Res Hum Retroviruses (1994) 1.25
Ecological and epidemiological data on Hantavirus in bank vole populations in Belgium. Arch Virol (1986) 1.24
Cloning, nucleotide sequence, and expression of the Brucella melitensis bp26 gene coding for a protein immunogenic in infected sheep. FEMS Microbiol Lett (1996) 1.22
Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol (1999) 1.22
Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli. J Immunol (1991) 1.22
Phylogenetic analysis of a new chimpanzee lentivirus SIVcpz-gab2 from a wild-captured chimpanzee from Gabon. AIDS Res Hum Retroviruses (1994) 1.21
What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. AIDS (1999) 1.18
Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes. Clin Diagn Lab Immunol (1995) 1.18
Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet (1996) 1.17
A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. Ebola Virus Study Teams. J Infect Dis (1999) 1.17
Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol (1991) 1.15
Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS (1998) 1.14
Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire. Lancet (1992) 1.11
Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses (1995) 1.10
Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J Virol Methods (1997) 1.08
Isolation of HIV-1 RNA from plasma: evaluation of seven different methods for extraction (part two). J Virol Methods (1998) 1.08
Molecular characterization, occurrence, and immunogenicity in infected sheep and cattle of two minor outer membrane proteins of Brucella abortus. Infect Immun (1996) 1.08
A look at the P4 virus containment laboratory. Prog Med Virol (1982) 1.07
Risk factors for infection with human immmunodeficiency virus among European expatriates in Africa. BMJ (1988) 1.05
Comparison of enzyme immunoassays and an immunofluorescence test for detection of antibody to human immunodeficiency virus in African sera. Eur J Clin Microbiol (1987) 1.04
Redistribution of a murine humoral immune response following removal of an immunodominant B cell epitope from a recombinant fusion protein. Mol Immunol (1993) 1.02
Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection. J Clin Microbiol (1994) 1.01
Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort. AIDS (1993) 1.00
Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS (2000) 1.00
Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material. Lancet (1983) 1.00
Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals. Antimicrob Agents Chemother (1999) 0.99
Replication of arboviruses in mouse organ cultures. II. Multiplication of virulent and avirulent Semliki Forest and western equine encephalitis viruses in mouse organ cultures. Arch Virol (1975) 0.99
Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire. AIDS (1994) 0.98
Interaction of mouse peritoneal macrophages with different arboviruses in vitro. J Gen Virol (1977) 0.97
HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS (2001) 0.97
beta-D-xylosidase from Bacillus pumilus. Methods Enzymol (1982) 0.95
Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.95
Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees. AIDS (2001) 0.95
Assessment of a new immunoassay for serological confirmation and discrimination of human T-cell lymphotropic virus infections. Clin Diagn Lab Immunol (1998) 0.95
Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. J Virol Methods (1998) 0.95
Isolation of HIV-1 RNA from plasma: evaluation of eight different extraction methods. J Virol Methods (1996) 0.95
Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells. Virology (2001) 0.94
Comparison of immunofluorescence and enzyme-linked immunosorbent assays for the serology of Hantaan virus infections. J Virol Methods (1989) 0.93
Ankle-Knee prosthesis with powered ankle and energy transfer for CYBERLEGs α-prototype. IEEE Int Conf Rehabil Robot (2013) 0.93
Human cyclophilin has a significantly higher affinity for HIV-1 recombinant p55 than p24. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.93
Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. AIDS Res Hum Retroviruses (2000) 0.93
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. AIDS Res Hum Retroviruses (2000) 0.92
Hepatitis B virus: genotypes and subtypes in Brazilian hemodialysis patients. Artif Organs (1999) 0.90
Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. AIDS (1996) 0.90
Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant. J Virol (1997) 0.89
Evaluation of immunofluorescence and immunoperoxidase methods for antibody determination against Chikungunya, West Nile and yellow fever viruses. Ann Soc Belg Med Trop (1979) 0.89
Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol (1997) 0.89
Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing. AIDS (1998) 0.89
Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. AIDS Res Hum Retroviruses (1999) 0.88
Different hantavirus serotypes in western Europe. Lancet (1991) 0.88
Early detection of maedi-visna (ovine progressive pneumonia) virus seroconversion in field sheep samples. J Vet Diagn Invest (2001) 0.87
Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J Infect Dis (1995) 0.87
Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS (1998) 0.87
Genetic characterization of Puumala hantavirus strains from Belgium: evidence for a distinct phylogenetic lineage. Virus Res (2001) 0.87
Isolation in Vero-E6 cells of Hanta virus from Clethrionomys glareolus captured in the Bashkiria area of the U.S.S.R. Ann Soc Belg Med Trop (1984) 0.87
Genetic characterization of accessory genes from human immunodeficiency virus type 1 group O strains. AIDS Res Hum Retroviruses (1998) 0.87
Isolation of human immunodeficiency virus type 2 from a homosexual man in Belgium. Eur J Clin Microbiol Infect Dis (1988) 0.87
HIV-1 genetic variability in Cameroon. AIDS (2000) 0.86
Interpatient genetic variability of HIV-1 group O. AIDS (1999) 0.86